ALK27-001: A Study of Trospium Inhalation Powder (TrIP)Administered to Subjects With COPD

NCT00801684 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

24

Enrollment

INDUSTRY

Sponsor class

Conditions

Chronic Obstructive Pulmonary Disease (COPD)

Interventions

DRUG: Placebo
DRUG: TrIP-2D
DRUG: TrIP-2SS
DRUG: TrIP-2D
DRUG: TrIP-2SS + Foradil

Sponsor

Alkermes, Inc.